News & Updates
Filter by Specialty:
Handheld device-questionnaire combo improves COPD diagnosis
In patients with suspected chronic obstructive pulmonary disease (COPD), the combination of FEV1/FEV6 and COPD diagnostic questionnaire (CDQ) demonstrates the highest diagnostic accuracy as well as cost-effectiveness in detecting at-risk individuals, according to a Taiwan study.
Handheld device-questionnaire combo improves COPD diagnosis
25 Jul 2025
Predictive model identifies women with COPD in need of palliative care
A newly developed prediction model has demonstrated robust performance in recognizing women with chronic obstructive pulmonary disease (COPD) who might benefit from proactive palliative care. However, external validation is warranted.
Predictive model identifies women with COPD in need of palliative care
23 Jul 2025
Exercise-based rehab improves exercise capacity in long COVID patients
Results from the PHOSP-R* trial show that exercise-based rehabilitation (EBR) improves short-term exercise capacity in individuals with post-COVID syndrome (long COVID) following an acute hospitalization.
Exercise-based rehab improves exercise capacity in long COVID patients
21 Jul 2025
Subcutaneous on par with IV pembrolizumab for NSCLC
Pembrolizumab administered subcutaneously (SC) is noninferior to the intravenous (IV) strategy in terms of overall exposure and trough concentrations, with similar efficacy and consistent safety profiles in patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), reports a study.
Subcutaneous on par with IV pembrolizumab for NSCLC
17 Jul 2025
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.